The FDA has approved Gemtesa® for men with overactive bladder symptoms receiving pharmacological therapy for BPH.

Urinary incontinence, or leakage of urine, is a very common condition for women of all ages, ethnicities and backgrounds.

A football fan who has stage four prostate cancer is backing a campaign for sanitary bins to be put in men's toilets at ...

WHEN was the last time you thought about your pelvic floor? Maybe never? If so, it’s time to start paying some attention as ...

Sumitomo Pharma's Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive ...

Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive bladder (OAB) s ...

The study found that Focal One's treatment methods match up with the gold star standard of surgery, and improve quality of life outcomes.

Medical experts share their answers to all your questions on bladder problems, from urinary tract infections to odd urine ...

Many people believe that urinary tract infections (UTIs) and incontinence are more common in women, but they can also affect ...

The US subsidiary of Japan’s Sumitomo Pharma announced that the US Food and Drug Administration (FDA) has approved Gemtesa ...

Twenty-four years ago, Hollywood was introduced to the glorious cast of characters known as the X-Men, and it hasn’t looked back since. The past two decades has seen a whopping 14 movies based ...

Background: Urinary incontinence (UI), particularly urge urinary incontinence ... Conclusion: This study showed a negative correlation between CDAI and UUI incidence in the group of men with low CDAI ...